BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21228024)

  • 1. Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis.
    Ceccarelli A; Rocca MA; Perego E; Moiola L; Ghezzi A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2011 Jun; 17(6):702-7. PubMed ID: 21228024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis.
    Ceccarelli A; Rocca MA; Neema M; Martinelli V; Arora A; Tauhid S; Ghezzi A; Comi G; Bakshi R; Filippi M
    Mult Scler; 2010 Jan; 16(1):39-44. PubMed ID: 19965516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential changes in deep and cortical gray matters of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Zhou F; Zee CS; Gong H; Shiroishi M; Li J
    J Comput Assist Tomogr; 2010; 34(3):431-6. PubMed ID: 20498549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.
    Zhang Y; Metz LM; Yong VW; Mitchell JR
    J Neurol Sci; 2010 Oct; 297(1-2):76-81. PubMed ID: 20708201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.
    Zivadinov R; Schirda C; Dwyer MG; Haacke ME; Weinstock-Guttman B; Menegatti E; Heininen-Brown M; Magnano C; Malagoni AM; Wack DS; Hojnacki D; Kennedy C; Carl E; Bergsland N; Hussein S; Poloni G; Bartolomei I; Salvi F; Zamboni P
    Int Angiol; 2010 Apr; 29(2):158-75. PubMed ID: 20351672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
    Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
    Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
    Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
    Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis.
    Yu CS; Lin FC; Liu Y; Duan Y; Lei H; Li KC
    Eur J Radiol; 2008 Nov; 68(2):328-34. PubMed ID: 17928182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Khalil M; Enzinger C; Langkammer C; Tscherner M; Wallner-Blazek M; Jehna M; Ropele S; Fuchs S; Fazekas F
    Mult Scler; 2009 Sep; 15(9):1048-54. PubMed ID: 19556316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).
    Chen X; Zeng C; Luo T; Ouyang Y; Lv F; Rumzan R; Wang Z; Li Q; Wang J; Hou H; Huang F; Li Y
    Eur J Radiol; 2012 Apr; 81(4):e633-9. PubMed ID: 22280874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis.
    Zhang Y; Zabad R; Wei X; Metz L; Hill M; Mitchell J
    Mult Scler; 2007 Aug; 13(7):880-3. PubMed ID: 17468444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
    Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain macro- and microscopic damage in patients with paediatric MS.
    Absinta M; Rocca MA; Moiola L; Ghezzi A; Milani N; Veggiotti P; Comi G; Filippi M
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1357-62. PubMed ID: 20660915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.